Before becoming a hematologist, Tamara Dunn performed “off-off Broadway” and fronted a funk band. Now, she works to foster diverse communities in medicine.
The music therapy program at Lucile Packard Children's Hospital Stanford brings hope and healing to young patients in need of an interlude of inspiration.
Women scheduled for C-sections know the levels of pain relief they'll need, and are happier with their experience if given a choice.
Stanford geneticists discuss the future of genomics, including the importance of studying diverse populations for medical research.
Some viruses help drug-resistant bacteria grow in the lungs of cystic fibrosis patients, new Stanford research shows.
A soon-to-graduate medical student talks about the challenges of studying and practicing medicine and encourages doctors-in-training to ask for help when they need it.
A Stanford psychologist discusses the future of psychiatric artificial intelligence, including the challenges and potential benefits for AI-based mental health assessment.
Award-winning artist Joel Slayton led a workshop to spur Stanford biomedical researchers to tap into their playful side by building a nest for a toy drone.
Rise with Refugees, held recently on campus, featured slam poetry and discussions about how to improve the lives and health of refugees.
Results from a multi-center clinical trial show that a drug lowers the risk of kidney failure by a third in people with Type 2 diabetes and kidney disease.
A Stanford-led study of preschoolers in Pakistan identifies three factors that can help kids develop executive function and resilience.
Recent Stanford research on the importance of a particular gene in aging can be traced to a casual conversation between roommates.
Scientists from the MyHeart Counts research study have released data from 50,000 participants to enable additional investigations.
NASA and collaborating institutes, including Stanford, have examined the molecular and genetic differences between two twin astronauts.
Stanford researchers have created an algorithm to detect familial hypercholesterolemia, a hard-to-diagnose genetic disease.
Stanford scientists and collaborators have harnessed CRISPR to replace the mutated gene underpinning the devastating immune disease, SCID-X1.